跳至主要内容
临床试验/NCT03970629
NCT03970629终止不适用

ROSA Total Knee Investigational Testing Authorization Study: Prospective Single Center Study of the ROSA Total Knee System

Zimmer Biomet2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2019年6月20日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Zimmer Biomet
入组人数
19
试验地点
2
主要终点
Oxford Knee Score Questionnaire

研究概览

简要总结

This is a prospective, single-center clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic System or conventional instrumentation.

详细描述

The primary objective of this study is to collect and compare clinical outcomes and surgical data using the ROSA Total Knee robotic instrumentation and conventional instrumentation in primary total knee arthroplasty.

The assessments will include: Planned vs actual component positioning; Workflow efficiency; Patient safety based on incidence and frequency of adverse events; Clinical performance measured by overall pain and function, quality of life data, and radiographic parameters.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is a minimum of 18 years of age
  • Pre-op component positioning and sizing plan prior to surgery
  • Independent of study participation, patient is a candidate for primary TKA using the commercially available Persona knee components implanted in accordance with product labeling
  • Patient has participated in this study-related Informed Consent process
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form
  • Patient is willing and able to complete scheduled study procedures and follow-up evaluations

排除标准

  • Patient is currently participating in any other surgical intervention studies or pain management studies
  • Patient has underwent contralateral UKA or TKA within the last 18 months
  • Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum)
  • Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture, chronic severe dislocation)
  • Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)
  • Patient has previously received partial or total knee arthroplasty for the ipsilateral knee

结局指标

主要结局

Oxford Knee Score Questionnaire

时间窗: 1 year

Oxford Knee Score

EQ-5D questionnaire

时间窗: 1 year

EQ-5D

次要结局

未报告次要终点

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验